LSK Global PS Appoints Jung-Min Lee as the

                                                  New Executive Director of CDM Headquarters

- LSK Global PS promotesJung-Min Lee as the new Executive Director of CDM Headquarters

- Recognized as an expert in the related field based onsuccessful role as the head of the department and establishment of the LSKGlobal PS PV department 

[November 1, 2017] South Korea’s leading contract research organization(CRO) LSK Global PS (LSK Global Pharma Services Co., Ltd.) announced onNovember 1^st that it had newly appointed Lee Jung-Min as theExecutice Director  of CDM (Clinical Data Management) headquarters. Withthe newly appointed Executive Director Jung-Min Lee,LSK Global PS will continueto strengthen its position as a partner for the successful development of newdomestic drugs and advancement of domestic pharmaceutical companies into theglobal market through more systematic operations and more expertise from theCDM headquarters.

Jung-Min Lee is an undergraduate from EwhaWomen’s University College of Pharmacy and achieved Foreign Pharmacy GraduateExamination Committee (FPGEC) Certification, National Association of Boards ofPharmacy, US.  Sincethen, she has gained competence and leadership as a specialist in the relatedindustry working under the core departments of various pharmaceutical companiesand CROs including clinical trials and pharmacovigilance(PV).  Lee joinedLSK Global PS CDM headquarters in 2012 as Clinical Data Associate (CDA) andlater successfully served as the Head of CDM Department. In addition, Lee wasone of pioneering members to form LSK Global PS’ PV department for the firsttime in Korea, providing services for drug monitoring before and after themarket release. After, Lee has been the head of LSK Global PS’Pharmacovigilance Department since 2014, showing competence as a leading expertin the related field. Since 2013, she has actively participated as an officialmember of the International Society of Pharmacovigilance.

LSK Global PS CDM Headquarters, headed bynew Executive Director LeeJung-Min, is Korea’s largest CDM headquartersmade of 80 experts in clinical trial data, including 22 personnels with mastersand doctorals. The CDM headquarters operates a Clinical Data Management systemthat meets US FDA standards with high quality and strict management of clinicaltrial data. To produce the best quality of data, a team of Clinical DataAssociates with expert knowledge and IT specialists Database Administrators(DBA) form the management system from start to finish of clinical trials.

LSK Global PS provides services and datathrough the CDM systems meeting international ICH standards and globalrequirements as well as regulations. As evidence, a total of 926 clinicaltrials (as of June 30, 2017) have been conducted with a number of globalclinical trials and projects for major Korean pharmaceutical companies.

# # #